Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3220 results found

2025 ∙ Tiozzo, G. de Roo, A. M. Hofstra, H. S. Gurgel do Amaral, G. S. Vondeling, G. T. Postma, M. J. Freriks, R. D.

Safety of live attenuated vaccines in immunocompromised individuals and pregnant women: a systematic literature review

  • All age groups
  • Pregnant women
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Garcia Flores, A. B. Ruiz-Montero, R. Onieva-Garcia, M. A. Batista-Duharte, A. Lopez Cabrera, E. Farouk Allam, M. Salcedo, I.

Safety Profile of the 4CMenB (Bexsero<sup></sup>) Vaccine: A Systematic Review and Meta-Analysis of Adverse Events in Clinical Trials

  • All age groups
  • Meningococcal disease
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Thone, P. Egger, M. Gruber, M. S. Gruber, G. Kasassov, C. Nyiri, D. Weis, E. Werl, H. Trinkl, L. Lilleby, W. Clodi, M. Brautigam, E. Dieplinger, B. Aigner, A. Geinitz, H.

Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Radiation-Oncology Patients: A Systematic Review and Meta-Analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Chiavarini, M. Genga, A. Ricciotti, G. M. D'Errico, M. M. Barbadoro, P.

Safety, Immunogenicity, and Efficacy of Cytomegalovirus Vaccines: A Systematic Review of Randomized Controlled Trials

  • All age groups
  • Cytomegalovirus
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Al-omoush, O. Khalil, L. Ramadan, A. Tarakhan, H. Alzoubi, A. Nabil, A. Hajali, M. Abdelazeem, B. Saleh, O.

Sarcoidosis and COVID-19 Vaccines: A Systematic Review of Case Reports and Case Series

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Bylica, I. Jachowicz-Matczak, E. Brodowicz, J. Su Bociąga-Jasik, M. Heczko, P. Gagatek, S. Bylica, J. W

SARS-CoV-2 Vaccine-Induced Humoral Immunity in Immunocompetent European Adults: A Systematic Review

  • Europe
  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Zeleke, A. M. Tassew, W. C. Bayeh, G. M. Ayale Ferede, Y.

Satisfaction with maternal health services and associated factors among parents in Ethiopia: a systematic review and meta-analysis

  • Africa
  • Ethiopia
  • Parents/caregivers
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Ma, R. Du, Y. Jing, W. Ma, H. Wang, K. Liu, A. Chen, S. Zhou, M. Zhou, Y. Su, S. Zhang, L. Yang, Y.

Seasonal influenza vaccination rate and vaccine effectiveness among older adults in mainland China: A systematic review and meta-analysis

  • Western Pacific
  • China
  • Adults
  • Older adults
  • Influenza
  • Coverage
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Ma, K. S. K. Shen, C. H. Chiang, M. H. Blumenthal, K. G. Chen, S. T.

Severe Cutaneous Adverse Reactions Following Vaccination: A Systematic Review and Meta-Analysis

  • All age groups
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Wan, S. Zhang, S. Hu, S. Luo, C. Liu, G. Ramos da Conceicao, L. D. Costa Encarnacao, M. D. Zhao, L. Y.

Should routine HPV vaccination programs include males 25-29 years? A systematic review and global meta-analysis

  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
  • Coverage
Methodological quality (AMSTAR 2):
Critically low
Loading...